Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: A single-center clinical observational study

Journal of Neurosurgery

Volumn 124, Issue 1, 2016, Pages 51-58

  Ehlert, Angelika ^a   Schmidt, Christoph ^b   Wölfer, Johannes ^b   Manthei, Gerd ^a   Jacobs, Andreas H ^c   Brüning, Roland ^d   Heindel, Walter ^b   Ringelstein, E Bernd ^b   Stummer, Walter ^b   Pluta, Ryszard M ^e   Hesselmann, Volker ^b,f  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c European Institute for Molecular Imaging   (Germany)

^d ASKLEPIOS HOSPITAL BARMBEK   (Germany)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^f Asklepios Hospital Hamburg   (Germany)

Author keywords

CVS; DIND; Molsidomine; NO; Subarachnoid hemorrhage; Vascular disorders; Vasospasm

Indexed keywords

MOLSIDOMINE; NIMODIPINE; VASODILATOR AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN INFARCTION; BRAIN VASOSPASM; COIL EMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DELAYED ISCHEMIC NEUROLOGICAL DEFICIT; DRUG DOSE TITRATION; DRUG HALF LIFE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HYPOTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RANKIN SCALE; SUBARACHNOID HEMORRHAGE; UNSPECIFIED SIDE EFFECT; BRAIN ISCHEMIA; COMBINATION DRUG THERAPY; COMPLICATION; HEMODYNAMICS; MIDDLE AGED; MORTALITY; NERVOUS SYSTEM DISEASES; PROSPECTIVE STUDY; STROKE; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN INFARCTION; BRAIN ISCHEMIA; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MOLSIDOMINE; NERVOUS SYSTEM DISEASES; NIMODIPINE; PROSPECTIVE STUDIES; STROKE; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL; YOUNG ADULT;

EID: 84966393367     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2014.12.JNS13846     Document Type: Article

References (33)

1. Al-Khindi T, Macdonald RL, Schweizer TA: Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke 41:e519-e536, 2010
2. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, et al: Cerebral arterial spasm-a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 308:619-624, 1983
3. Bassenge E, Pohl U, Busse R: Generation and transmission of vasoactive and antiaggregatory signals by the endothelium. Adv Second Messenger Phosphoprotein Res 24:434-440, 1990
4. Bassenge E, Schneider HT, Daiber A: [Oxidative stress and cardiovascular diseases.] Dtsch Med Wochenschr 130:2904-2909, 2005 (Ger)
5. Bevan JA, Bevan RD, Walters CL, Wellman T: Functional changes in human pial arteries (300 to 900 micrometer ID) within 48 hours of aneurysmal subarachnoid hemorrhage. Stroke 29:2575-2579, 1998
6. Busse R, Trogisch G, Bassenge E: The role of endothelium in the control of vascular tone. Basic Res Cardiol 80:475-490, 1985
7. Casthely PA, Cottrell JE, Patel KP, Marlin A, Turndorf H: Cerebrospinal fluid cyanide after nitroprusside infusion in man. Can Anaesth Soc J 28:228-231, 1981
8. Dirnagl U, Becker K, Meisel A: Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use. Lancet Neurol 8:398-412, 2009
9. Dorsch NW: Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care 8:128-133, 2002
10. Dreier JP, Ebert N, Priller J, Megow D, Lindauer U, Klee R, et al: Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg 93:658-666, 2000
11. Faraci FM: Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation. Am J Physiol 261:H1038-H1042, 1991
12. Faraci FM, Brian JE Jr: Nitric oxide and the cerebral circulation. Stroke 25:692-703, 1994
13. Frontera JA, Fernandez A, Schmidt JM, Claassen J, Wartenberg KE, Badjatia N, et al: Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke 40:1963-1968, 2009
14. Komotar RJ, Schmidt JM, Starke RM, Claassen J, Wartenberg KE, Lee K, et al: Resuscitation and critical care of poorgrade subarachnoid hemorrhage. Neurosurgery 64:397-411, 2009
15. Kramer A, Fletcher J: Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis. Stroke 40:3403-3406, 2009
16. Loch Macdonald R: Management of cerebral vasospasm. Neurosurg Rev 29:179-193, 2006
17. Nolan CP, Macdonald RL: Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm? Neurosurg Focus 21(3):E1, 2006
18. Ohkuma H, Manabe H, Tanaka M, Suzuki S: Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 31:1621-1627, 2000
19. Pluta RM: Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 105:23-56, 2005
20. Pluta RM, Dejam A, Grimes G, Gladwin MT, Oldfield EH: Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. JAMA 293:1477-1484, 2005
21. Pluta RM, Hansen-Schwartz J, Dreier J, Vajkoczy P, Macdonald RL, Nishizawa S, et al: Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 31:151-158, 2009
22. Pluta RM, Rak R, Wink DA, Woodward JJ, Khaldi A, Oldfield EH, et al: Effects of nitric oxide on reactive oxygen species production and infarction size after brain reperfusion injury. Neurosurgery 48:884-893, 2001
23. Pluta RM, Thompson BG, Afshar JK, Boock RJ, Iuliano B, Oldfield EH: Nitric oxide and vasospasm. Acta Neurochir Suppl 77:67-72, 2001
24. Rinkel GJ, Algra A: Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol 10:349-356, 2011
25. Rosenkranz B, Winkelmann BR, Parnham MJ: Clinical pharmacokinetics of molsidomine. Clin Pharmacokinet 30:372-384, 1996
26. Senbokuya N, Kinouchi H, Kanemaru K, Ohashi Y, Fukamachi A, Yagi S, et al: Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial. J Neurosurg 118:121-130
27. Serruys PW, Deckers JW, Luijten HE, Reiber JH, Tijssen JG, Chadha D, et al: Long-acting coronary vasodilatory action of the molsidomine metabolite Sin 1: a quantitative angiographic study. Eur Heart J 8:263-270, 1987
28. Smith RR, Clower BR, Grotendorst GM, Yabuno N, Cruse JM: Arterial wall changes in early human vasospasm. Neurosurgery 16:171-176, 1985
29. Sobey CG, Faraci FM: Subarachnoid haemorrhage: what happens to the cerebral arteries? Clin Exp Pharmacol Physiol 25:867-876, 1998
30. Stein SC, Browne KD, Chen XH, Smith DH, Graham DI: Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study. Neurosurgery 59:781-788, 2006
31. Ursino M: Regulation of the circulation of the brain, in Bevan RD, Bevan JA (eds): The Human Brain Circulation: Functional Changes in Disease. New York: Humana Press, 1994, pp pp. 291-318
32. Vergouwen MD, Vermeulen M, Coert BA, Stroes ES, Roos YB: Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 28:1761-1770, 2008
33. Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, et al: Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 41:2391-2395, 2010